Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 5Recruiting 3Completed 3Unknown 1Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell 1Lymphoma 1HTLV-I Infections 1

Interventions

Cyclophosphamide 4Vincristine 3Rituximab 3Prednisone 3zanubrutinib 2Doxorubicin 2tisagenlecleucel 1sargramostim 1prednylidene 1fludarabine 1deltacortene 1brincidofovir 1axicabtagene ciloleucel 1Methods 1Immunotherapy, Active 1Immunization, Passive 1Epirubicin 1E7777 fusion protein 1Drug Therapy 1Coal Tar 1CT-P10 1Biological Therapy 1Antibodies, Monoclonal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Lymphoma, Large B-Cell, Diffuse × prednylidene × Clear all
NCT04850495 2026-06-04

Zanubrutinib in Combination With R-PolaCHP (ZaR-PolaCHP) for Newly Diagnosed Diffuse Large B-Cell Lymphoma

Ohio State University Comprehensive Cancer Center

Phase 1 Suspended
38 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡